EDITORIAL
Published on 16 Jul 2024
Editorial: Targeting regulatory cells in cancer: old and new approaches in immunotherapy
doi 10.3389/fimmu.2024.1458280
- 684 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Targeting Regulatory Cells in Cancer: Old and New Approaches in Immunotherapy
Targeting Regulatory Cells in Cancer: Old and New Approaches in Immunotherapy
5,809
Total downloads
20k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 04 Apr 2024
A novel dual mechanism-of-action bispecific PD-1-IL-2v armed by a “βγ-only” interleukin-2 variant
doi 10.3389/fimmu.2024.1369376
- 3,546 views
MINI REVIEW
Published on 04 Mar 2024
Targeting tumor-infiltrating tregs for improved antitumor responses
doi 10.3389/fimmu.2024.1325946
- 2,773 views
- 9 citations
ORIGINAL RESEARCH
Published on 25 Jan 2024
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells
doi 10.3389/fimmu.2024.1346686
- 2,095 views
- 6 citations
REVIEW
Published on 08 Jan 2024
A new target of radiotherapy combined with immunotherapy: regulatory T cells
doi 10.3389/fimmu.2023.1330099
- 1,827 views
- 3 citations
REVIEW
Published on 03 Nov 2023
Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches
doi 10.3389/fimmu.2023.1280601
- 2,575 views
- 5 citations
ORIGINAL RESEARCH
Published on 27 Oct 2023
Targeting regulatory T cells by E7777 enhances CD8 T-cell–mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models
doi 10.3389/fimmu.2023.1268979
- 2,021 views
- 1 citation
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 20kTopic views
- 13kArticle views
- 5,809Article downloads